Hikma Pharmaceuticals PLC operates through three core business segments: Injectables, Generics (Hikma Rx), and Branded. The Injectables segment is the company's largest revenue driver, supplying hospitals and clinics globally with sterile generic and specialty products. The Generics segment focuses on the North American retail market, offering oral, respiratory, and specialty products. The Branded segment serves the MENA region with branded generics and in-licensed patented products, supported by a strong regional salesforce and local manufacturing facilities. With 29 manufacturing plants across 10 countries, Hikma competes with global generic pharmaceutical manufacturers by leveraging its specialized injectable capabilities and deep market penetration in emerging markets.
